Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 8/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.53 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | NNMT | P40261 | 3/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | PDE2A | O00408 | 1/20 | 0.31 |
| ▸ | PDE5A | O76074 | 1/20 | 0.31 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.31 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16613148 | 0.83 | HCRTR2 (0.42) | MTNR1AMTNR1BHCRTR2 | |
| SCHEMBL16612871 | 0.83 | HCRTR2 (0.36) | MTNR1AMTNR1BHCRTR2CXCR3 | |
| SCHEMBL16612982 | 0.80 | HCRTR2 (0.44) | MTNR1AMTNR1BHCRTR1HCRTR2NNMT | |
| SCHEMBL16612628 | 0.80 | HCRTR2 (0.43) | MTNR1AMTNR1BHCRTR1HCRTR2NNMT | |
| SCHEMBL16612854 | 0.80 | MTNR1A (0.52) | MTNR1AMTNR1BHCRTR1HCRTR2 | |
| SCHEMBL16612613 | 0.79 | MTNR1A (0.49) | MTNR1AHCRTR1HCRTR2PARP1 | |
| SCHEMBL16612831 | 0.78 | HCRTR2 (0.42) | MTNR1AMTNR1BHCRTR1HCRTR2 | |
| SCHEMBL16612868 | 0.78 | MTNR1A (0.49) | MTNR1AMTNR1BHCRTR1HCRTR2 | |
| SCHEMBL16613015 | 0.78 | HCRTR2 (0.41) | MTNR1AMTNR1BHCRTR2 | |
| SCHEMBL16612960 | 0.77 | HCRTR2 (0.41) | HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2675801-B1 | NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2015-04-08 | — | — | EP | claimed |